Titan Pharmaceuticals (NASDAQ:TTNP) Downgraded by Maxim Group

Share on StockTwits

Maxim Group downgraded shares of Titan Pharmaceuticals (NASDAQ:TTNP) from a buy rating to a hold rating in a research report released on Thursday, The Fly reports.

Separately, ValuEngine raised shares of Titan Pharmaceuticals from a sell rating to a hold rating in a research note on Thursday, August 1st.

Shares of NASDAQ TTNP opened at $0.47 on Thursday. Titan Pharmaceuticals has a 12-month low of $0.40 and a 12-month high of $5.04. The stock has a market cap of $6.25 million, a PE ratio of -0.60 and a beta of 0.99. The company has a current ratio of 1.27, a quick ratio of 1.86 and a debt-to-equity ratio of 1.18. The company has a 50-day moving average of $1.10 and a 200 day moving average of $1.47.

Titan Pharmaceuticals (NASDAQ:TTNP) last announced its quarterly earnings data on Wednesday, August 14th. The specialty pharmaceutical company reported ($0.38) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by ($0.21). Titan Pharmaceuticals had a negative net margin of 352.17% and a negative return on equity of 412.65%. The business had revenue of $0.50 million for the quarter, compared to analysts’ expectations of $1.30 million. On average, sell-side analysts forecast that Titan Pharmaceuticals will post -0.68 EPS for the current fiscal year.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Geode Capital Management LLC boosted its holdings in Titan Pharmaceuticals by 256.0% in the 4th quarter. Geode Capital Management LLC now owns 341,474 shares of the specialty pharmaceutical company’s stock valued at $76,000 after purchasing an additional 245,565 shares during the last quarter. A.R.T. Advisors LLC boosted its holdings in Titan Pharmaceuticals by 164.7% in the 2nd quarter. A.R.T. Advisors LLC now owns 69,645 shares of the specialty pharmaceutical company’s stock valued at $89,000 after purchasing an additional 43,333 shares during the last quarter. Finally, Vanguard Group Inc. boosted its holdings in Titan Pharmaceuticals by 23.0% in the 2nd quarter. Vanguard Group Inc. now owns 582,180 shares of the specialty pharmaceutical company’s stock valued at $746,000 after purchasing an additional 109,016 shares during the last quarter. 5.06% of the stock is owned by institutional investors.

Titan Pharmaceuticals Company Profile

Titan Pharmaceuticals, Inc, a pharmaceutical company, develops proprietary therapeutics for the treatment of serious medical disorders. It develops products based on ProNeura, a proprietary long-term drug delivery platform that focuses primarily on treatments for chronic diseases. The company offers Probuphine, a product candidate for maintenance treatment of opioid dependence, which maintains a stable, around the clock blood level of the drug buprenorphine in patients for six months following a single treatment.

Recommended Story: Stop Order

The Fly

Receive News & Ratings for Titan Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Wells Fargo & Company MN Has $10.58 Million Holdings in Jones Lang LaSalle Inc
Wells Fargo & Company MN Has $10.58 Million Holdings in Jones Lang LaSalle Inc
Wells Fargo & Company MN Purchases 12,591 Shares of IndexIQ ETF Trust – IQ Hedge Multi-Strategy Tracker ETF
Wells Fargo & Company MN Purchases 12,591 Shares of IndexIQ ETF Trust – IQ Hedge Multi-Strategy Tracker ETF
Wells Fargo & Company MN Has $10.17 Million Stock Position in Jefferies Financial Group Inc
Wells Fargo & Company MN Has $10.17 Million Stock Position in Jefferies Financial Group Inc
Wells Fargo & Company MN Sells 31,561 Shares of John Hancock Income Securities Trust
Wells Fargo & Company MN Sells 31,561 Shares of John Hancock Income Securities Trust
Wells Fargo & Company MN Cuts Position in CGI Inc
Wells Fargo & Company MN Cuts Position in CGI Inc
1ST TR ENERGY I/SH  Shares Sold by Wells Fargo & Company MN
1ST TR ENERGY I/SH Shares Sold by Wells Fargo & Company MN


© 2006-2019 Ticker Report